{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:54:40Z","timestamp":1785902080681,"version":"3.56.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.msard.2020.102065","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T12:24:30Z","timestamp":1584966270000},"page":"102065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Liver injury after methylprednisolone pulse therapy in multiple sclerosis is usually due to idiosyncratic drug-induced toxicity rather than autoimmune hepatitis"],"prefix":"10.1016","volume":"42","author":[{"given":"Hiroko","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4911-9320","authenticated-orcid":false,"given":"Akitoshi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Kikukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itsuki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshikazu","family":"Mino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawako","family":"Uchida-Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Ohsawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5731-798X","authenticated-orcid":false,"given":"Yoshiaki","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2020.102065_bib0001","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.msard.2018.07.021","article-title":"Toxic liver injury after high-dose methylprednisolone in people with multiple sclerosis","volume":"25","author":"Adamec","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5","key":"10.1016\/j.msard.2020.102065_bib0002","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.msard.2020.102065_bib0003","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1177\/1352458517692885","article-title":"Concurrent autoimmune hepatitis in multiple sclerosis","volume":"24","author":"Cacao","year":"2018","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2020.102065_bib0004","first-page":"199","article-title":"High-dose methylprednisolone-induced hepatitis in a patient with multiple sclerosis: a case report and brief review of literature","volume":"71","author":"D'Agnolo","year":"2013","journal-title":"Neth. J. Med."},{"issue":"11","key":"10.1016\/j.msard.2020.102065_bib0005","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs\u2013I. a novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"Danan","year":"1993","journal-title":"J. Clin. Epidemiol."},{"issue":"1","key":"10.1016\/j.msard.2020.102065_bib0006","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/1751-2980.12306","article-title":"Methylprednisolone-induced liver injury: case report and literature review","volume":"17","author":"Davidov","year":"2016","journal-title":"J. Dig. Dis."},{"issue":"6","key":"10.1016\/j.msard.2020.102065_bib0007","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1191\/1352458505ms1239oa","article-title":"Autoimmune hepatitis and multiple sclerosis: a coincidental association?","volume":"11","author":"de Seze","year":"2005","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.msard.2020.102065_bib0008","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/NRL.0000000000000029","article-title":"Methylprednisolone-induced toxic hepatitis after intravenous pulsed therapy for multiple sclerosis relapses","volume":"19","author":"Ferraro","year":"2015","journal-title":"Neurologist"},{"issue":"10","key":"10.1016\/j.msard.2020.102065_bib0009","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1007\/s00415-013-7041-9","article-title":"Comorbidities at multiple sclerosis diagnosis","volume":"260","author":"Fromont","year":"2013","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2020.102065_bib0010","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJMra1816149","article-title":"Drug-induced liver injury - tTypes and phenotypes","volume":"381","author":"Hoofnagle","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.msard.2020.102065_bib0011","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1177\/1352458510369146","article-title":"Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study","volume":"16","author":"Langer-Gould","year":"2010","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.msard.2020.102065_bib0012","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/1352458514564490","article-title":"A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.msard.2020.102065_bib0013","doi-asserted-by":"crossref","first-page":"e00968","DOI":"10.1002\/brb3.968","article-title":"Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients","volume":"8","author":"Nociti","year":"2018","journal-title":"Brain Behav."},{"key":"10.1016\/j.msard.2020.102065_bib0014","article-title":"Autoimmune hepatitis in patients with multiple sclerosis: the role of immunomodulatory treatment","author":"Rigopoulou","year":"2018","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"3","key":"10.1016\/j.msard.2020.102065_bib0015","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1386-6346(03)00232-8","article-title":"Assessment of 287 Japanese cases of drug induced liver injury by the diagnostic scale of the International Consensus Meeting","volume":"27","author":"Takikawa","year":"2003","journal-title":"Hepatol. Res."},{"issue":"4","key":"10.1016\/j.msard.2020.102065_bib0016","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/archneur.55.4.517","article-title":"Systemic autoimmune features and multiple sclerosis: a 5-year follow-up study","volume":"55","author":"Tourbah","year":"1998","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2020.102065_bib0017","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/2050640619840147","article-title":"Liver injury after methylprednisolone pulses: a disputable cause of hepatotoxicity. A case series and literature review","volume":"7","author":"Zoubek","year":"2019","journal-title":"United Eur. Gastroenterol. J."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820301413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820301413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:49:49Z","timestamp":1761900589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034820301413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":17,"alternative-id":["S2211034820301413"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102065","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver injury after methylprednisolone pulse therapy in multiple sclerosis is usually due to idiosyncratic drug-induced toxicity rather than autoimmune hepatitis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102065"}}